期刊
VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE
卷 49, 期 4, 页码 259-263出版社
HOGREFE AG-HOGREFE AG SUISSE
DOI: 10.1024/0301-1526/a000885
关键词
Thromboembolism; deep vein thrombosis; pulmonary embolism; D-dimers; COVID-19
As observed in other infections with a systemic inflammatory response, severe COVID-19 is associated with hypercoagulability and a prothrombotic state. Currently, there is growing evidence that pulmonary embolism and thrombosis contribute to adverse outcomes and increased mortality in critically ill patients with COVID-19. The optimal thromboprophylactic regimen for patients with COVID-19 is not known. Whereas pharmacologic thromboprophylaxis is generally recommended for all hospitalized COVID-19 patients, adequate dosing of anticoagulants remains a controversial issue. Therefore, we summarize current evidence from the available literature and, on behalf of the German Society of Angiology (DGA), we aim to provide advice to establish an improved and more uniform strategy for thromboprophylaxis in patients with COVID-19.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据